Sbir topic 131 - new award to vulcan biologics
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93024C00061
- Awardee
-
Vulcan Biologics Inc. UEI LNBVDMU2KNN5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,914
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · PHS20241 · Posted Jul 7, 2023
- Contract value 100% obligated
- $299,914.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92617, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $299,914 |
About this award
This is a $299,914 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Vulcan Biologics Inc., a small disadvantaged business, for the "Development of Bacteriophage for Treatment of Mycobacterial Infections." The contract stems from NIAID's SBIR solicitation PHS-2023-1, which sought proposals from small businesses to conduct innovative research supporting NIH and CDC mission needs in areas like infectious diseases. Vulcan Biologics specializes in modulating microbiomes using bacteriophages, and this contract will fund the initial development of their phage-based approach to treating mycobacterial infections. The contract has a firm fixed price and is set aside for small businesses.
Quick answers
Who was awarded contract 75N93024C00061?
75N93024C00061 was awarded to Vulcan Biologics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 10, 2024.
How much is contract 75N93024C00061 worth?
The government has obligated $299,914 on 75N93024C00061.
Was contract 75N93024C00061 competed?
The extent of competition for 75N93024C00061 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award